Farmasian teknologian laitos
Department of Pharmaceutical Technology

Julkaisut 1991
Publications 1991


1 Finne U et al. Effects of mixing on timolol release from matrices of isopropyl PVM-MA with and without a basic additive.
2 Finne U et al. Timolol release from matrices of monoesters of poly(vinyl methyl ether/maleic anhydride). The effects of polymer molecular weigt and a basic additive.
3 Finne U et al. Sodium acetate improves the ocular/systemic absorption ratio of timolol applied oculary in monoisopropyl PVM-MA matrices.
4 Finne U et al. In vitro/in vivo comparison of timolol maleate release from buffered and unbuffered matrices of monoisopropyl ester of poly(vinyl methyl ether/maleic anhydride).
5 Hirvonen J et al. Reversible enhancement of transdermal propranolol by dodecyl N,N-dimethyl amino acetate.
6 Hirvonen J et al. Dodecyl N,N-dimethylamino acetate and Azone enhance drug penetration across human, snake and rabbit skin.
7 Ilkka J, Paronen P. Predictability of compression behaviour of powder mixtures using the Heckel treatment.
8 Järvinen T et al. Synthesis and identification of pilocarpic acid diesters, prodrugs of pilocarpine.
9 Järvinen T et al. O,O'-(1,4-Xylylene) bispilocarpic acid esters as new potential double prodrugs of pilocarpine for improved ocular delivery. I. Synthesis and analysis.
10 Järvinen T et al. O,O'-(1,4-Xylylene) bispilocarpic acid esters as new potential double prodrugs of pilocarpine for improved ocular delivery. II. Physicochemical properties, stability, solubility and enzymatic hydrolysis.
11 Pesonen T. Material and direct compression properties of an agglomerated cellulose powder.
12 Saano V et al. Relative pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers.
13 Suhonen P et al. Permeability of pilocarpic acid diesters across albino rabbit cornea in vitro.
14 Suhonen P et al. Function of epithelia as a site of hydrolysis during corneal penetration of lipophilic pilocarpine prodrugs.
15 Suhonen P et al. Improved corneal pilocarpine permeability with O,O'-(1,4-Xylylene) bispilocarpic acid ester double prodrugs.
16 Urtti A. Silmälääkinnän kehitysnäkymistä.
17 Urtti A. Simulation of the absorptive membrane permeability effects on in vivo drug release from controlled release systems.
18 Vidgren M et al. Deposition and gastrointestinal transit of a conventional sucralfate tablet.
19 Vidgren M et al. Deposition and transition of sucralfate after administration from conventional and affervescent tablets.
20 Vidgren M et al. Dissolution and pharmacokinetic profiles of conventional and effervescent tablets and soft gelatin capsules containing ibuprofen.
21 Vidgren M et al. In vitro dissolution and pharmacokinetic evaluation of two filmcoated and an effervescent tablet of ibuprofen.
22 Vidgren M et al. Physical properties and clinical efficacy of two sodium cromoglycate inhalation aerosol preparations.
23 Vidgren P et al. In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols.
24 Vidgren P et al. Preparation and in vitro evaluation of disodium cromoglycate microspheres for nasal administration.
25 Vidgren P et al. In vitro deposition and clinical efficacy of two disodium cromoglycate inhalation powders.
26 Vidgren P et al. Removal of the inhaled 99mTc-labelled particles of disodium cromoglycate from the lungs.
27 Vidgren P et al. In vitro and in vivo evaluation of nasal mucoadhesion of disodium cromoglycate microspheres.
28 Vidgren P et al. Double-labelling technique in the evaluation of disodium cromoglycate microspheres.

Farmasian teknologian laitos Department of Pharmaceutical Technology
Julkaisutietokanta 22.05.1997 Publications Data Base 22.05.1997